Clinical trial · Observational
Impact of Multidisciplinary and Radiologic Review on Outcome of Pancreatic Cancer Patients: an Observational Study
Impatto Della Revisione Radiologica Con Valutazione Multidisciplinare Nella Gestione Terapeutica Dei Pazienti Affetti da Adenocarcinoma Pancreatico (PAC)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators compared two different time periods respectively before and after the application of a dedicated diagnostic and therapeutic protocol for pancreatic ductal adenocarcinoma including multidisciplinary discussion and radiological review of cases, in order to evaluate the impact of the new protocol on surgical failures and overall survival.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Ductal Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| application of a diagnostic and therapeutic protocol (multidisciplinary discussion and radiological CT review) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- PDAC patients diagnosed in 2008-2011
- label
- PDAC patients diagnosed in 2013-2016
- interventionNames
- Other: application of a diagnostic and therapeutic protocol (multidisciplinary discussion and radiological CT review)
Primary outcomes (1)
- measure
- Proportion of surgical failures on the total of eligible patients
- timeFrame
- immediately after surgery
- description
- proportion of patients with incomplete resection or who received surgery in which resection was not possible
Secondary outcomes (2)
- measure
- Overall survival
- timeFrame
- 24 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * all consecutive inhabitants of the Reggio Emilia province with incident PDACs in 2008-2011 and 2013-2016 periods Exclusion Criteria: * pancreatic cancers with cytohistological diagnosis different from PDAC, * diagnosis in 2012, * metastatic disease at diagnosis (stage IV) or unknown stage at diagnosis, * patients aged \>85 years.
References
Publications (0)
Data not yet available